Trump names Andrew Ferguson as head of Federal Trade Commission to replace Lina KhanFor those who need to travel or commute during the day, make sure to check the weather forecast and road conditions beforehand. Slow down and drive carefully on icy or slippery roads to ensure your safety and the safety of others. Public transportation or carpooling can be good alternatives to driving in extreme weather conditions.'Putin Most Sensible': Indian Diplomat & Ex-Foreign Secy On Trump's Ukraine Plan I Kanwal Sibal Recommended Playlist 'Putin Most Sensible': Indian Diplomat & Ex-Foreign Secy On Trump's Ukraine Plan I Kanwal Sibal 'Why I Didn't Set My Farm On Fire This Year' | Delhi pollution | I Witness George Soros Echoes In Indian Parliament; Heated Fight Over Sonia-Soros Link Accusation I Watch Is India's batting now over dependent on Yashasvi Jaiswal? Rohit Sharma has had a terrible time with the bat in whites How can India still qualify for World Test Championship final? CCTV captures chaos as BEST bus crashes into Kurla market Bomb attack outside Gurgaon nightclub 'Will Pay Heavy Price': Trump's 'Army' Threatens NATO Nation After Big Action In Syria Saudi's MBS Scolds Israel; Announces 'United Front' Against Aggression In Syria | Watch Top Viral Videos Shocking! Lawyer rams Mercedes car into Kachori shop in Delhi, Six injured In a shocking incident, six people were injured after a lawyer rammed his speeding Mercedes car into a Kachori shop in the national capital. The incident took place at Fateh Kachori in Civil Lines area. The police have taken the lawyer into custody and seized his car. The lawyer has been identified as Parag Maini who is a resident of Noida’s Sector 79. The police have registered a case against the lawyer under Section 279 (rash driving) and 337 (causing hurt by endangering life). Telangana cop punched, dragged by villagers, video goes viral On Cam: Crane drags car with senior citizens sitting inside, case registered | video goes viral Instagram influencer shot dead by husband in Rajasthan's Phalodi CCTV: Thieves arrive in car, decamp with jewellery in MP's Damoh Goons hurl abuses at toll plaza employee in MP's Chhatarpur Two goons hurled abuses at a toll plaza employee in Madhya Pradesh’s Chhatarpur. One of the assailants is reportedly the brother of an MLA. The incident was filmed by an employee of ol plaza which has gone viral on social media. The goons were upset after they had to wait in the queue. Viral: Cobra blocks road in MP's Chhatarpur district Nigeria: Lion kills zookeeper at Obafemi Awolowo University CCTV: Biker crushed to death by speeding bus in Madhya Pradesh's Ujjain district Four women steal tray full of earrings from a jewellery shop in MP's Raisen Shirtless British man punches air steward after destroying aircraft toilet, arrested A shirtless British man punched an air steward after destroying the aircraft toilet. The man was arrested. The man went berserk soon after the flight took off . He went up to smash the plane’s toilet. The incident took place on February 7 when the flight took off from Bangkok to London. A video of the incident went viral on social media. On cam: Several injured after swarm of bees attacks guests during wedding ceremony in MP's Guna On cam: Man hurls abuses at government school teacher in MP's Chhatarpur district On cam: Man thrashes youth with stick in MP's Ujjain Doctor loses cool, misbehaves with home guard in MP's Chhatarpur On cam: Goons thrash Dalit youth in MP's Betul A Dalit youth was thrashed in Madhya Pradesh’s Betul. The man was brutally thrashed and forced to squat while holding his ears. A video of the incident has gone viral on social media. Congress leader Jitu Patwari highlighted the plight of the Dalit man. The police have launched a probe into the matter. On cam: Govt employee consumes alcohol at work place in MP's Singrauli On cam: Goons thrash liquor shop employee in MP's Gwalior CCTV: Man thrashed, abducted in Madhya Pradesh's Betul district Fight breaks out between CHC employee and patient in UP's Barabanki Short Videos BJP Orchestrated Attack On Kejriwal During ‘Padyatra’ Campaign: Delhi CM Atishi Your Autistic Child Can Also Make A Difference Your Autistic Child Can Also Make A Difference Kejriwal Questions RSS Over BJP’s 'Dirty' Tactics Against Opposition | Watch Atishi's 1st Statement After Being Picked As Delhi CM; 'Kejriwal Made Biggest Sacrifice' Kejriwal To Give Up CM Residence; AAP's Sanjay Singh Issues Big Warning... Haryana Polls: Vinesh Phogat & Bajrang Punia Join Congress; Sakshi Malik next? Putin's Big Pledge For Russian Speakers In Ukraine; 'Will Fight For...' Ukraine’s Kursk Incursion Has Failed To Achieve Objectives, Declares Putin Putin Says Russia Will Support Kamala Harris In U.S. Elections Related Articles Zelenskyy seeks diplomatic end to Russia's war, floats role for foreign troops Trump calls for 'immediate' cease-fire in Ukraine and says a US withdrawal from NATO is possible 'Assad is gone, Putin not interested in protecting him': Trump on Syrian crisis US unveils $725 million military aid package for Ukraine, including landmines and anti-air weapons How US President-elect Trump's pick Keith Kellogg want to end Russia-Ukraine war? Russian defence minister visits North Korea for talks with military, political leaders Ex-Google CEO Schmidt to the US Army: Give tanks away, instead buy a ... Trump's pick for top security advisor Mike Waltz calls for 'responsible end' to Russia-Ukraine war
Against the backdrop of a rapidly growing e-commerce sector, the issue of intellectual property protection has become more critical than ever. With the rise of online counterfeiting, copyright infringement, and trademark violations, businesses are facing unprecedented threats to their brands, products, and innovations. The need for robust legal frameworks, effective enforcement mechanisms, and proactive strategies to combat IP infringements has never been more pressing.The ban on DJI and Da Jiang Innovations would not only impact the companies themselves but also have far-reaching implications for the drone industry as a whole. As the world's largest drone manufacturer, DJI plays a central role in shaping the market and driving innovation in drone technology. A ban on DJI drones in the US could disrupt supply chains, limit consumer choice, and stifle competition, ultimately hindering the growth and development of the industry.
Hegseth meets with moderate Sen. Collins as he lobbies for key votes in the SenateSchiff condemns Trump’s jail time threat but says Biden preemptive pardons not ‘necessary’
As the Premier League season progresses, fans can look forward to more thrilling matches, standout performances, and exciting developments both on and off the pitch. The talents of players like Palmer and Vardy, coupled with the leadership of coaches like Maresca, continue to elevate the quality of football in the English top-flight league, captivating audiences around the world.
“What do you do? You wack the C.E.O. at the annual parasitic bean-counter convention. It’s targeted, precise, and doesn’t risk innocents.” Those lines reportedly come from a notebook found in the possession of Luigi Mangione , the 26-year-old man suspected of killing UnitedHealthcare CEO Brian Thompson. After Mangione was taken into custody earlier this week at a McDonald’s in Altoona, Pennsylvania, the public has slowly begun to learn about the man that police believe committed one of the most audacious murders in living memory. That murder, which took place on Dec. 4th in midtown Manhattan, saw Thompson gunned down in front of his hotel by a masked assailant. Security camera footage shows a figure dressed in gray attire who, after killing Thompson, stepped onto an e-bike and rode away. Bullet casings found at the crime scene were etched with the words “deny,” “defend” and “depose”—which some have speculated may reference a book about the healthcare industry. Now, police say they have gotten their hands on a notebook belonging to Mangione. The New York Times reports that the notebook “detailed plans for the shooting,” and also “described going to a conference and killing an executive.” The Times report doesn’t shed much light on the other contents of the notebook, writing that the lines that had been shared were communicated to the paper by two law enforcement officials. It’s possible that, as criminal proceedings progress, more of the notebook’s contents may be shared. Mangione is also thought to have written a “manifesto,” which law enforcement sources claim is legitimate. This supposed document was published online earlier this week by independent journalist Ken Klippenstein and, in one section, reads: “I do apologize for any strife of traumas but it had to be done. Frankly, these parasites simply had it coming. A reminder: the US has the #1 most expensive healthcare system in the world, yet we rank roughly #42 in life expectancy.” The manifesto also mentions a “spiral notebook” that the document states should “illuminate the gist of it,” seeming to allude to motivations for the shooting. Thompson’s death has predictably polarized the internet—and America. Rightwing influencers almost immediately sought to portray Mangione as a leftist, with LibsofTikTok calling him an “anti-capitalist climate-change activist.” Meanwhile, left-leaning accounts were more than happy to lionize the young man, with many people commenting on Mangione’s good looks, and others expressing support for killing corporate executives. Indeed, a broad, bipartisan dislike of the healthcare industry has made itself known over the past week, with many people expressing their disdain for it via jokes and memes , many of which have been made at the murdered healthcare executive’s expense. That said, a clear picture of Mangione’s personal politics hasn’t yet emerged. The Wall Street Journal referred to him as an “Ivy Leaguer with Anticapitalist Leanings.” The scouring of Mangione’s public-facing social media accounts has turned up a hodgepodge of interests and political leanings that don’t seem to fit into a coherent partisan picture. He did reportedly leave a favorable book review on Goodreads of Ted Kaczynski, the former promising young mathematician who took part in a CIA mind control experiment in the 1950s and went on to become “the Unabomber,” an anarchist terrorist who mailed bombs to people. It’s been reported that Mangione is from a wealthy, well-connected family and that he previously worked as a computer programmer. A video posted online shows the young man giving a valedictorian speech at his private prep school graduation in 2016. At some point, Mangione suffered a debilitating back injury . He is said to have abruptly dropped off the radar in the months before the shooting, prompting some to speculate that something happened during that period to radicalize him towards violence. Mangione’s mother reportedly filed a missing person’s report with the San Francisco Police Department on Nov. 18th.
A fugitive gains fame in New Orleans eluding dart guns and netsWord of the Rolls-Royce owner's selfless act quickly spread throughout the community, inspiring others to follow his lead and pay it forward. Social media was abuzz with messages of admiration and gratitude for his kindness, with many praising his willingness to put others' needs ahead of his own.
AP News Summary at 6:21 p.m. ESTTo the dismay of many eager buyers, the delivery time for the Nintendo alarm clock seemed to stretch on indefinitely. What was initially thought to be a quick and seamless process turned into a waiting game that tested the patience of even the most dedicated fans. Some customers reported receiving vague updates from the company, citing manufacturing delays and logistical challenges as the cause of the prolonged wait.
Title: Canadian Prime Minister's Firm Response to Trump's Tariffs and Preparation of Various Countermeasures
NAARDEN, The Netherlands and MIAMI, Dec. 10, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced the commencement of an underwritten public offering of $300.0 million of the Company’s ordinary shares, nominal value €0.12 per share (the “Ordinary Shares”), and, to certain investors that so choose in lieu of Ordinary Shares, pre-funded warrants to purchase Ordinary Shares (“Pre-Funded Warrants,” and such offering, the “Offering”). All Ordinary Shares and Pre-Funded Warrants to be sold in the proposed Offering will be sold by the Company. In addition, the Company expects to grant the underwriters a 30-day option to purchase up to an additional $45.0 million of Ordinary Shares, less underwriting discounts and commissions. The proposed Offering is subject to market and other conditions and there can be no assurance as to whether or when the proposed Offering may be completed, or as to the actual size or terms of the proposed Offering. Jefferies, Goldman Sachs & Co., Leerink Partners, TD Cowen, Guggenheim Securities and William Blair are acting as joint book-running managers for the proposed Offering. The proposed Offering will be made pursuant to a registration statement on Form S-3, including a base prospectus, that was initially declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on July 12, 2024. The proposed Offering will be made only by means of a prospectus supplement and an accompanying prospectus, which will be filed with the SEC and will be available on the SEC’s website located at www.sec.gov . A copy of the preliminary prospectus supplement and the accompanying prospectus, when available, may also be obtained from: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, or by telephone at (877) 821-7388, or by email at Prospectus_Department@Jefferies.com ; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, or by telephone at (866) 471-2526, or by email at Prospectus-ny@ny.email.gs.com ; Leerink Partners LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, or by telephone at (800) 808-7525, ext. 6105, or by email at syndicate@leerink.com ; TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, NY 10017, or by telephone at (855) 495-9846, or by email at TD.ECM_Prospectus@tdsecurities.com ; Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue, New York, NY 10017, or by telephone at (212) 518-9544, or by email at GSEquityProspectusDelivery@guggenheimpartners.com ; or William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, or by telephone at (800) 621-0687, or by email at prospectus@williamblair.com . This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About NewAmsterdam NewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well-tolerated. We seek to fill a significant unmet need for a safe, well-tolerated and convenient LDL-lowering therapy. In multiple phase 3 studies, NewAmsterdam is investigating obicetrapib, an oral, low-dose and once-daily CETP inhibitor, alone or as a fixed-dose combination with ezetimibe, as LDL-C lowering therapies to be used as an adjunct to statin therapy for patients at risk of CVD with elevated LDL-C, for whom existing therapies are not sufficiently effective or well-tolerated. Forward-Looking Statements Certain statements included in this document that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the consummation of the proposed Offering as well as the timing and size of the proposed Offering and the grant to the underwriters of the option to purchase additional Ordinary Shares. These statements are based on various assumptions, whether or not identified in this document, and on the current expectations of the Company’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and may differ from assumptions. Many actual events and circumstances are beyond the control of the Company. These forward-looking statements are subject to a number of risks and uncertainties, including changes in domestic and foreign business, market, financial, political, and legal conditions; risks related to the approval of the Company’s product candidate and the timing of expected regulatory and business milestones, including potential commercialization; ability to negotiate definitive contractual arrangements with potential customers; the impact of competitive product candidates; ability to obtain sufficient supply of materials; global economic and political conditions, including the Russia-Ukraine and Israel-Hamas conflicts; the effects of competition on the Company’s future business; and those factors described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as supplemented by other documents filed by the Company with the SEC. Additional risks related to the Company’s business include, but are not limited to: uncertainty regarding outcomes of the Company’s ongoing clinical trials, particularly as they relate to regulatory review and potential approval for its product candidate; risks associated with the Company’s efforts to commercialize a product candidate; the Company’s ability to negotiate and enter into definitive agreements on favorable terms, if at all; the impact of competing product candidates on the Company’s business; intellectual property related claims; the Company’s ability to attract and retain qualified personnel; and the Company’s ability to continue to source the raw materials for its product candidate. If any of these risks materialize or the Company’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company does not presently know or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company’s expectations, plans, or forecasts of future events and views as of the date of this document and are qualified in their entirety by reference to the cautionary statements herein. The Company anticipates that subsequent events and developments may cause the Company’s assessments to change. These forward-looking statements should not be relied upon as representing the Company’s assessment as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements. Neither the Company nor any of its affiliates undertakes any obligation to update these forward-looking statements, except as may be required by law. Company Contact Matthew Philippe P: 1-917-882-7512 matthew.philippe@newamsterdampharma.com Media Contact Spectrum Science on behalf of NewAmsterdam Pharma Jaryd Leady P:1-856-803-7855 jleady@spectrumscience.com Investor Contact Precision AQ on behalf of NewAmsterdam Austin Murtagh P: 1-212-698-8696 austin.murtagh@precisionaq.comUpon arrival, the police conducted a thorough investigation of the scene, ruling out any signs of forced entry or struggle. Preliminary reports suggest that the woman may have succumbed to natural causes, with further forensic analysis pending to determine the exact cause of death.